Barclays’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $260K | Buy |
|
|||||
|
2025
Q2 | $135K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4K | Sell |
|
|||||
|
2024
Q1 | $29K | Sell |
|
|||||
|
2023
Q4 | $47K | Buy |
|
|||||
|
2023
Q3 | $13K | Sell |
|
|||||
|
2023
Q2 | $26K | Sell |
|
|||||
|
2023
Q1 | $141K | Sell |
|
|||||
|
2022
Q4 | $316K | Buy |
|
|||||
|
2022
Q3 | $166K | Sell |
|
|||||
|
2022
Q2 | $322K | Sell |
|
|||||
|
2022
Q1 | $496K | Sell |
|
|||||
|
2021
Q4 | $983K | Buy |
|
|||||
|
2021
Q3 | $782K | Buy |
|
|||||
|
2021
Q2 | $393K | Sell |
|
|||||
|
2021
Q1 | $867K | Buy |
|
|||||
|
2020
Q4 | $251K | Sell |
|
|||||
|
2020
Q3 | $282K | Sell |
|
|||||
|
2020
Q2 | $536K | Buy |
|
|||||
|
2020
Q1 | $216K | Sell |
|
|||||
|
2019
Q4 | $1.11M | Buy |
|
|||||
|
2019
Q3 | $1.07M | Buy |
|
|||||
|
2019
Q2 | $657K | Sell |
|
|||||
|
2019
Q1 | $1.26M | Sell |
|
|||||
|
2018
Q4 | $961K | Buy |
|
|||||
|
2018
Q3 | $701K | Sell |
|
|||||
|
2018
Q2 | $1.7M | Buy |
|
|||||
|
2018
Q1 | $99K | Sell |
|
|||||
|
2017
Q4 | $244K | Sell |
|
|||||
|
2017
Q3 | $1.17M | Sell |
|
|||||
|
2017
Q2 | $1.49M | Buy |
|
|||||
|
2017
Q1 | $1.37M | Buy |
|
|||||
|
2016
Q4 | $620K | Buy |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $2K | Buy |
|
|||||
|
2016
Q1 | $2K | Sell |
|
|||||
|
2015
Q4 | $35K | Sell |
|
|||||
|
2015
Q3 | $133K | Buy |
|
|||||
|
2015
Q2 | $5K | Sell |
|
|||||
|
2015
Q1 | $5K | Buy |
|
|||||
|
2014
Q4 | $4K | Buy |
|
|||||
|
2014
Q3 | $1K | Buy |
|
|||||
|
2014
Q2 | $1K | Sell |
|
|||||
|
2014
Q1 | $3K | Buy |
|